Complementary therapies, herbs, and other OTC agents

ONCOLOGY

Volumn 22, Issue 11, 2008, Pages 1319-

  Cassileth, Barrie ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERBACEOUS AGENT; NON PRESCRIPTION DRUG; SILYBUM MARIANUM EXTRACT;

ABDOMINAL PAIN; ALTERNATIVE MEDICINE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CHEMOTHERAPY INDUCED EMESIS; COLLAPSE; DIARRHEA; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED PRACTICE; HERB DRUG INTERACTION; HUMAN; INFORMATION DISSEMINATION; INTERNET; LIVER DISEASE; MENSTRUATION DISORDER; NAUSEA; NONHUMAN; ONCOLOGY; SILYBUM MARIANUM; SWEAT GLAND DISEASE; UTERUS DISEASE; VITAMIN SUPPLEMENTATION; WEAKNESS;

EID: 56049086142     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Saller R, Brignoli R, Melzer J, et al: An updated systematic review with meta-analysis for the clinical evidence of silymarin. Forsch Komplementmed 15:9-20, 2008.
2. Rambaldi A, Jacobs BP, Gluud C: Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases. Cochrane Database Syst Rev (4): CD003620, 2007.
3. Huseini HF, Larijani B, Heshmat R, et al: The efficacy of Silybum marianum (L) Gaertn. (silymarin) in the treatment of type II diabetes: A randomized, double-blind, placebo-controlled, clinical trial. Phytother Res 20:1036-1039, 2006.
4. Ramasamy K, Agarwal R: Multitargeted therapy of cancer by silymarin. Cancer Lett May 8, 2008.
5. Kohno H, Tanaka T, Kawabata K, et al: Silymarin, a naturally occurring polyphenolic antioxidant flavonoid, inhibits azoxymethane-induced colon carcinogenesis in male F344 rats. Int J Cancer 101:461-468, 2002.
6. Adverse Drug Reactions Advisory Committee: An adverse reaction to the herbal medication milk thistle (Silybum marianum). Med J Aust 170:218-219, 1999.